Home/Filings/4/0001127602-21-013910
4//SEC Filing

Toth Christopher A. 4

Accession 0001127602-21-013910

CIK 0000203527other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 7:49 PM ET

Size

17.9 KB

Accession

0001127602-21-013910

Insider Transaction Report

Form 4
Period: 2021-04-15
Toth Christopher A.
SVP and Pres. Oncology Systems
Transactions
  • Disposition to Issuer

    Common Stock

    2021-04-1515,4180 total
  • Disposition to Issuer

    Restricted Stock Units

    2021-04-151,8160 total
    Common Stock (1,816 underlying)
  • Disposition to Issuer

    Performance Shares

    2021-04-158,4370 total
    Common Stock (8,437 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2021-04-156330 total
    Common Stock (633 underlying)
  • Disposition to Issuer

    Performance Shares

    2021-04-156,4150 total
    Common Stock (6,415 underlying)
Footnotes (8)
  • [F1]Amount of securities disposed of reflect 196 shares purchased on April 8, 2021 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan and a reduction of 8 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
  • [F2]Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
  • [F4]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
  • [F5]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
  • [F6]Each performance stock unit represents a contingent right to receive one share of VAR common stock.
  • [F7]Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
  • [F8]Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.

Issuer

VARIAN MEDICAL SYSTEMS INC

CIK 0000203527

Entity typeother

Related Parties

1
  • filerCIK 0001753950

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 7:49 PM ET
Size
17.9 KB